| Full Name | Ann Iannitto |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | Psc 475 Box 1, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477955607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 235673 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ann Iannitto, Psc 475 Box 1368, Fpo, AP 96350-9998 Ph: () - | Ann Iannitto, Psc 475 Box 1, Fpo, AP 96350-1200 Ph: (315) 243-8658 |
News Archive
Scientists from Weill Cornell Medical College and Houston Methodist have found that a gene previously unassociated with breast cancer plays a pivotal role in the growth and progression of the triple negative form of the disease, a particularly deadly strain that often has few treatment options. Their research, published in this week's Nature, suggests that targeting the gene may be a new approach to treating the disease.
Only one in five non-fatal alcohol overdoses results from use of alcohol alone, according to a study of patients in a large addiction treatment facility, with most alcohol overdoses involving concomitant use of other drugs.
A major study shows that a minimally-invasive procedure is as effective and safe as the gold standard for treating blockages of the carotid artery, giving patients who prefer a less invasive procedure a proven alternative.
UNIVERSITY of Huddersfield researcher Yeshwanth Pulijala is dedicated to bringing about big improvements in medical training by harnessing the power of virtual reality and 3D technology. Now, he is part of a team that has developed the prototype for an innovative tool that will enable doctors to develop their communication skills - including the breaking of bad news - by conducting a simulated interview with a virtual patient.
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare announced that they have initiated the first of two Phase 3 clinical trials evaluating the efficacy and safety of VEGF Trap-Eye, an investigational new agent for the treatment of certain eye diseases, in the treatment of Diabetic Macular Edema.
› Verified 5 days ago
Ms. Kathi Susan Levitan, Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: U.s. Embassy Beijing, Unit 7300, Fpo, AP 96521 Phone: 861-085-314777 Fax: 861-085-313888 | |
Renee M Quezada, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-8747 | |
Catherine Anne Luna, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: Usnh Okinawa, Psc 482, Fpo, AP 96362 Phone: 011-816-117430228 Fax: 011-816-117430228 | |
Dr. Chaia Mcadams, DNP, CNM, WHNP-BC Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Us Naval Hospital Okinawa, Camp Foster, Fpo, AP 96362 Phone: 098-971-9355 | |
Megan Lynn King, DNP Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Psc 482, U.s. Naval Hospital Okinawa, Japan, Fpo, AP 96362 Phone: 098-646-7918 | |
Candace Foura, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: Psc 475, Fpo, AP 96350 Phone: 315-243-8747 |